Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant for prevention of menstrually related migraine
NL-OMON34533Phase 3Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of telcagepant, sponsored by Merck & Co. Started Aug 2010; status: active, not recruiting.
02
Drugs
telcagepant
Beyond the preview
Go deeper on NL-OMON34533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34533.